Literature DB >> 17096125

[Condylomata acuminata: an indication for prophylactic HPV vaccination?].

P Schneede1, B Schlenker, E Hungerhuber.   

Abstract

HPV infection is one of the most common sexually transmitted infections worldwide. Although most infections are transient, persistent ones can lead to condylomata acuminata, genital intraepithelial neoplasia and genital cancer. The recent approval of vaccines against HPV has raised great hopes. Since 1990, 5,392 urological investigations for HPV were carried out in 1,792 men in special HPV centres. We report on the epidemiology and natural course of condylomata, techniques for HPV detection, treatment surveillance and long-term sequelae. Condylomata acuminata proved to be pathognomonic; partner infections were diagnosed in 50% and more. Systematic HPV DNA analyses in partner investigations or as screening investigations cannot be recommended. Ultimately, within the spectrum of therapeutic options for condylomata, no method is really superior to others; recurrences occurred in 30-70% of cases. We definitely need the HPV vaccination programme to get rid of one of the oldest and up to now unsolved problems of mankind.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17096125     DOI: 10.1007/s00120-006-1232-2

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  19 in total

1.  Photodynamic investigation of mucosa-associated human papillomavirus efflorescences.

Authors:  P Schneede; A Leunig; P Hillemanns; S Wagner; A G Hofstetter
Journal:  BJU Int       Date:  2001-07       Impact factor: 5.588

2.  Evaluation of HPV testing by Hybrid Capture II for routine gynecologic screening.

Authors:  P Schneede; P Hillemanns; F Ziller; A Hofstetter; E Stockfleth; R Arndt; T Meyer
Journal:  Acta Obstet Gynecol Scand       Date:  2001-08       Impact factor: 3.636

Review 3.  Genital human papillomavirus infections.

Authors:  Peter Schneede
Journal:  Curr Opin Urol       Date:  2002-01       Impact factor: 2.309

4.  Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial.

Authors:  Diane M Harper; Eduardo L Franco; Cosette M Wheeler; Anna-Barbara Moscicki; Barbara Romanowski; Cecilia M Roteli-Martins; David Jenkins; Anne Schuind; Sue Ann Costa Clemens; Gary Dubin
Journal:  Lancet       Date:  2006-04-15       Impact factor: 79.321

5.  [European Association of Urology guidelines on urinary and male genital tract infections].

Authors:  P Schneede; A G Hofstetter; K G Naber; W Vahlensieck; M Ludwig; D Bach; H W Bauer; G Beyaert; H Blenk; Th Bootz; A Friesen; G Geiges; H-W Himstedt; W Hochreiter; H-J Keller; H-J Knopf; S Lenk; B Liedl; R Michaelis; L Neubauer; H Piechota; J Rassler; G Riedasch; K-H Rothenberger; K Rüdiger; H-J Schmitz; G Stadie; U Thiel; M C Truss; F M E Wagenlehner; W Weidner; M Westenfelder; B Göckel-Beining; A Heidenreich; H Rübben; K Schalkhäuser; W Thon; J W Thüroff; W Weidner
Journal:  Urologe A       Date:  2003-02-06       Impact factor: 0.639

6.  [Urethral condylomas. A therapeutic challenge].

Authors:  P Schneede; P Münch; F Ziller; A Hofstetter
Journal:  Hautarzt       Date:  2001-05       Impact factor: 0.751

7.  Vaccination against multiple HPV types.

Authors:  Elamin H Elbasha; Alison P Galvani
Journal:  Math Biosci       Date:  2005-09       Impact factor: 2.144

8.  [Human papillomaviruses (HPV) in urology. II: 10 years evaluation of differential HPV therapy].

Authors:  P Schneede; A Hofstetter
Journal:  Urologe A       Date:  2002-01       Impact factor: 0.639

9.  Recurrence of condylomata acuminata of the urethra after conventional and fluorescence-controlled Nd:YAG laser treatment.

Authors:  D Zaak; A Hofstetter; D Frimberger; P Schneede
Journal:  Urology       Date:  2003-05       Impact factor: 2.649

10.  [Laser applications in condylomata acuminata].

Authors:  P Schneede; R Muschter
Journal:  Urologe A       Date:  1994-07       Impact factor: 0.639

View more
  6 in total

1.  [Proven and new methods in the treatment of genital warts].

Authors:  P Schneede; R Waidelich
Journal:  Urologe A       Date:  2013-10       Impact factor: 0.639

Review 2.  [Human papillomavirus disease burden in men : HPV prevention is a man's business].

Authors:  P Schneede
Journal:  Urologe A       Date:  2018-12       Impact factor: 0.639

Review 3.  [Anogenital warts and HPV-associated precancers : Looking into the recently passed German S2k guideline].

Authors:  P Schneede; B Schlenker
Journal:  Urologe A       Date:  2018-04       Impact factor: 0.639

Review 4.  [One decade of HPV vaccination in Germany].

Authors:  P Schneede
Journal:  Urologe A       Date:  2017-06       Impact factor: 0.639

5.  [HPV in urology. Basic principles and controversies].

Authors:  P Schneede; R Waidelich
Journal:  Urologe A       Date:  2013-09       Impact factor: 0.639

Review 6.  [Viral infections in urology].

Authors:  G Magistro; A Pilatz; P Schneede; L Schneidewind; F Wagenlehner
Journal:  Urologe A       Date:  2021-07-06       Impact factor: 0.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.